Liver Cancer script

For more information regarding this feature, contact George Stamatis by sending e-mail to gxs18@po.cwru.edu or by calling 1-800-368-CWRU.

LIVER CANCER VACCINE (running time 2:08)

SUGGESTED INTRO: MEDICAL RESEARCHERS IN CLEVELAND HAVE DEVELOPED A CANCER VACCINE THAT CURES LIVER CANCER IN RATS. THIS DEVELOPMENT COULD LEAD TO VACCINES THAT WILL TREAT A VARIETY OF HUMAN CANCERS. MORE IN THIS REPORT:

VOICEOVER: LIVER CANCER AND OTHER CANCERS ARE ABLE TO AVOID THE BODY'S CANCER-KILLING CELLS BY DISGUISING THEMSELVES. BUT THAT MAY CHANGE IF A VACCINE THAT HAS SUCCESSFULLY TREATED LIVER CANCER IN RATS PROVES EFFECTIVE FOR HUMANS. RESEARCHERS AT CASE WESTERN RESERVE UNIVERSITY HAVE FUSED WHITE BLOOD CELLS CALLED B CELLS WITH LIVER TUMOR CELLS FROM RATS, CREATING A HYBRID CELL. WHEN RE-INTRODUCED TO THE CANCER SITE, THE FUSED CELLS ALLOWED THE IMMUNE SYSTEMS OF THE RATS TO SEE THE CANCER AND KILL IT. DOCTOR MAN-SUN SY IS ONE OF THE UNIVERSITY'S CANCER RESEARCHERS.

SOT & SUGGESTED SUPER:

DR. MAN-SUN SY, CWRU

PROF. OF PATHOLOGY

(OUTCUE: "... one thing at a time.") ( :23)

VOICEOVER: THE FUSED HYBRID CELLS WERE ALSO ABLE TO PROTECT HEALTHY ANIMALS FROM LIVER CANCER WHEN CANCER WAS INTRODUCED, ACTING LIKE A VACCINE. CLINICAL TESTING OF THE VACCINE WILL SOON BEGIN ON HUMAN PATIENTS IN SHANGHAI, CHINA. CASE WESTERN RESERVE'S DR. YA-JUN GUO, DEVELOPER OF THE VACCINE, IS HOPEFUL THAT HUMAN TRIALS CAN TAKE PLACE IN THIS COUNTRY IN THE NEAR FUTURE.

SOT & SUGGESTED SUPER:

DR. YA-JUN GUO, CWRU

CANCER RESEARCHER

DEVELOPED CANCER VACCINE

(OUTCUE: "... T-cell recognize it and kill it.") ( :22)

RESEARCHERS SAY SIMILAR VACCINES CAN BE DEVELOPED TO FIGHT ADDITIONAL TYPES OF CANCER, BUT THEY WILL HAVE TO BE CUSTOM-ENGINEERED TO FIGHT SPECIFIC CANCERS USING CELLS FROM THE INDIVIDUAL AFFECTED. THEY ALSO STRESS THAT SUCCESSFULLY TREATING HUMAN CANCERS WILL BE MUCH MORE DIFFICULT.

THIS IS TOM SHROUT REPORTING FROM CASE WESTERN RESERVE UNIVERSITY, CLEVELAND.

-CWRU-